These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 10343194

  • 1. Phase I study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in advanced non-small cell lung cancer.
    Fujita A, Takabatake H, Tagaki S, Sekine K.
    Oncology; 1999; 56(4):301-7. PubMed ID: 10343194
    [Abstract] [Full Text] [Related]

  • 2. Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer.
    Fujita A, Takabatake H, Tagaki S, Sekine K.
    Cancer Chemother Pharmacol; 2000; 45(4):279-83. PubMed ID: 10755315
    [Abstract] [Full Text] [Related]

  • 3. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 4. Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer.
    Fujita A, Ohkubo T, Hoshino H, Takabatake H, Tagaki S, Sekine K, Abe S.
    Br J Cancer; 2003 Sep 15; 89(6):1008-12. PubMed ID: 12966417
    [Abstract] [Full Text] [Related]

  • 5. Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer.
    Masuda N, Fukuoka M, Kudoh S, Kusunoki Y, Matsui K, Nakagawa K, Hirashima T, Tamanoi M, Nitta T, Yana T.
    J Clin Oncol; 1994 Jan 15; 12(1):90-6. PubMed ID: 7505810
    [Abstract] [Full Text] [Related]

  • 6. Combination of cisplatin, ifosfamide, and irinotecan with rhG-CSF support for the treatment of refractory or relapsed small-cell lung cancer.
    Fujita A, Takabatake H, Tagaki S, Sekine K.
    Oncology; 2000 Aug 15; 59(2):105-9. PubMed ID: 10971167
    [Abstract] [Full Text] [Related]

  • 7. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
    Masuda N, Fukuoka M, Kudoh S, Matsui K, Kusunoki Y, Takada M, Nakagawa K, Hirashima T, Tsukada H, Yana T.
    J Clin Oncol; 1994 Sep 15; 12(9):1833-41. PubMed ID: 7521905
    [Abstract] [Full Text] [Related]

  • 8. [Phase I study of cisplatin, ifosfamide and CPT11 with granulocyte colony-stimulating factor support in advanced non-small cell lung cancer].
    Fujita A, Takabatake H, Tagaki S, Sekine K.
    Gan To Kagaku Ryoho; 1996 Sep 15; 23(10):1285-90. PubMed ID: 8831740
    [Abstract] [Full Text] [Related]

  • 9. A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer.
    Masters GA, Mauer AM, Hoffman PC, Wyka D, Samuels BL, Krauss SA, Watson S, Golomb H, Vokes EE.
    Ann Oncol; 1998 Jun 15; 9(6):677-80. PubMed ID: 9681085
    [Abstract] [Full Text] [Related]

  • 10. Phase I study of carboplatin, docetaxel and irinotecan with recombinant human granulocyte colony stimulating factor support in patients with advanced non-small cell lung cancer.
    Fujita A, Takabatake H, Tagaki S, Sekine K.
    Anticancer Drugs; 2000 Nov 15; 11(10):821-4. PubMed ID: 11142689
    [Abstract] [Full Text] [Related]

  • 11. Phase I study of carboplatin, irinotecan and docetaxel on a divided schedule with recombinant human granulocyte colony stimulating factor support in patients with stage IIIB or IV non-small cell lung cancer.
    Fujita A, Ohkubo T, Hoshino H, Takabatake H, Tagaki S, Sekine K.
    Anticancer Drugs; 2002 Jun 15; 13(5):505-9. PubMed ID: 12045462
    [Abstract] [Full Text] [Related]

  • 12. Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer.
    Masters GA, Hoffman PC, Hsieh A, Drinkard LC, Mick R, Samuels BL, Guaspari A, Golomb HM, Vokes EE.
    J Clin Oncol; 1997 Mar 15; 15(3):884-92. PubMed ID: 9060524
    [Abstract] [Full Text] [Related]

  • 13. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Hoffman PC, Masters GA, Drinkard LC, Krauss SA, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Jun 15; 23(3 Suppl 6):11-5. PubMed ID: 8677441
    [Abstract] [Full Text] [Related]

  • 14. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
    Shinkai T, Arioka H, Kunikane H, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Oshita F, Nishio M, Karato A.
    Cancer Res; 1994 May 15; 54(10):2636-42. PubMed ID: 8168091
    [Abstract] [Full Text] [Related]

  • 15. Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer.
    Oshita F, Yamada K, Kato Y, Ikehara M, Noda K, Tanaka G, Nomura I, Suzuki R, Saito H.
    Cancer Chemother Pharmacol; 2003 Jul 15; 52(1):73-8. PubMed ID: 12750839
    [Abstract] [Full Text] [Related]

  • 16. A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.
    Graziano SL, Valone FH, Herndon JE, Crawford J, Richards F, Rege VB, Clamon G, Green MR.
    Lung Cancer; 1996 Jun 15; 14(2-3):315-29. PubMed ID: 8794413
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ, Fournel P, Bohas CH, Fortune IC, Chatte G.
    Semin Oncol; 1996 Apr 15; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [Abstract] [Full Text] [Related]

  • 18. Clinical studies of irinotecan alone and in combination with cisplatin.
    Fukuoka M, Masuda N.
    Cancer Chemother Pharmacol; 1994 Apr 15; 34 Suppl():S105-11. PubMed ID: 8070018
    [Abstract] [Full Text] [Related]

  • 19. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
    Johnson FM, Kurie JM, Peeples BO, Lee JJ, Feng L, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS.
    Clin Lung Cancer; 2003 Jul 15; 5(1):40-5. PubMed ID: 14596703
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.